Literature DB >> 26435775

Ankylosing spondylitis: A state of the art factual backbone.

Mohammad Ghasemi-Rad1, Hosam Attaya1, Emal Lesha1, Andrea Vegh1, Tooraj Maleki-Miandoab1, Emad Nosair1, Nariman Sepehrvand1, Ali Davarian1, Hamid Rajebi1, Abdolghader Pakniat1, Seyed Amirhossein Fazeli1, Afshin Mohammadi1.   

Abstract

Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects 1% of the general population. As one of the most severe types of spondyloarthropathy, AS affects the spinal vertebrae and sacroiliac joints, causing debilitating pain and loss of mobility. The goal of this review is to provide an overview of AS, from the pathophysiological changes that occur as the disease progresses, to genetic factors that are involved with its onset. Considering the high prevalence in the population, and the debilitating life changes that occur as a result of the disease, a strong emphasis is placed on the diagnostic imaging methods that are used to detect this condition, as well as several treatment methods that could improve the health of individuals diagnosed with AS.

Entities:  

Keywords:  Ankylosing spondylitis; Computed tomography; Diagnosis; Magnetic resonance imaging; Treatment; Ultrasound

Year:  2015        PMID: 26435775      PMCID: PMC4585948          DOI: 10.4329/wjr.v7.i9.236

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  145 in total

1.  Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.

Authors:  A Spoorenberg; D van der Heijde; E de Klerk; M Dougados; K de Vlam; H Mielants; H van der Tempel; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Feasibility of second-generation ultrasound contrast media in the detection of active sacroiliitis.

Authors:  Andrea S Klauser; Tobias De Zordo; Rosa Bellmann-Weiler; Gudrun M Feuchtner; Michaela Sailer-Höck; Peter Sögner; Johann Gruber
Journal:  Arthritis Rheum       Date:  2009-07-15

Review 3.  Effects of physical therapy for the management of patients with ankylosing spondylitis in the biological era.

Authors:  Erika Giannotti; Sabina Trainito; Giovanni Arioli; Vincenzo Rucco; Stefano Masiero
Journal:  Clin Rheumatol       Date:  2014-05-07       Impact factor: 2.980

4.  Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study.

Authors:  L E Kristensen; A K Jakobsen; J Askling; F Nilsson; L T H Jacobsson
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

5.  Effect of cardiovascular training on fitness and perceived disease activity in people with ankylosing spondylitis.

Authors:  Karin Niedermann; Eduard Sidelnikov; Claudia Muggli; Hanne Dagfinrud; Matthias Hermann; Giorgio Tamborrini; Adrian Ciurea; Heike Bischoff-Ferrari
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-11       Impact factor: 4.794

6.  An exploration of the impact of anti-TNFα medication on exercise behaviour in patients with ankylosing spondylitis.

Authors:  Jennifer Stockdale; James Selfe; Hazel Roddam
Journal:  Musculoskeletal Care       Date:  2014-02-19

7.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

8.  Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy.

Authors:  P V Balint; D Kane; H Wilson; I B McInnes; R D Sturrock
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

9.  Predominant association of HLA-B*2704 with ankylosing spondylitis in Chinese Han patients.

Authors:  Y Liu; L Jiang; Q Cai; P Danoy; M C N M Barnardo; M A Brown; H Xu
Journal:  Tissue Antigens       Date:  2009-10-04

10.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more
  14 in total

Review 1.  Diffuse idiopathic skeletal hyperostosis (DISH) - A common but less known cause of back pain.

Authors:  Raju Vaishya; Vipul Vijay; Ifeanyi Charles Nwagbara; Amit K Agarwal
Journal:  J Clin Orthop Trauma       Date:  2016-12-02

2.  The relationship of serum endocan levels and anti-TNF-alpha therapy in patients with ankylosing spondylitis.

Authors:  Fatma Zehra Kadayıfçı; Makbule Gezmen Karadağ
Journal:  Eur J Rheumatol       Date:  2018-03

3.  Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study.

Authors:  Donatella Maria Rodio; Elena Anzivino; Monica Mischitelli; Anna Bellizzi; Rossana Scrivo; Daniela Scribano; Gianlorenzo Conte; Carla Prezioso; Maria Trancassini; Guido Valesini; Anna Teresa Palamara; Valeria Pietropaolo
Journal:  Front Microbiol       Date:  2016-05-10       Impact factor: 5.640

4.  Association of Genetic Variants in Pentraxin 3 Gene with Ankylosing Spondylitis.

Authors:  Xu Zhang; Wenyuan Ding
Journal:  Med Sci Monit       Date:  2016-08-18

5.  Role and Function of A2A and A₃ Adenosine Receptors in Patients with Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid Arthritis.

Authors:  Annalisa Ravani; Fabrizio Vincenzi; Alessandra Bortoluzzi; Melissa Padovan; Silvia Pasquini; Stefania Gessi; Stefania Merighi; Pier Andrea Borea; Marcello Govoni; Katia Varani
Journal:  Int J Mol Sci       Date:  2017-03-24       Impact factor: 5.923

6.  Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis: A case-control study.

Authors:  Yuan-Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis.

Authors:  Yu Wang; Xiao-Dong Yi; Hai-Lin Lu
Journal:  Med Sci Monit       Date:  2017-04-12

Review 8.  The Importance of Recognizing Diffuse Idiopathic Skeletal Hyperostosis for Neurosurgeons: A Review.

Authors:  Masatoshi Yunoki; Kenta Suzuki; Atsuhito Uneda; Shuichi Okubo; Koji Hirashita; Kimihiro Yoshino
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-03-28       Impact factor: 1.742

9.  Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry.

Authors:  Philip J Mease; Désirée van der Heijde; Chitra Karki; Mei Liu; Yujin Park; Jeffrey D Greenberg
Journal:  Rheumatol Ther       Date:  2018-10-23

10.  Heart Involvement in a Moroccan Population with Spondyloarthritis: A Cross-sectional Study.

Authors:  Jalila Eddarami; Hamida Azzouzi; Linda Ichchou
Journal:  J Saudi Heart Assoc       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.